BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26845073)

  • 1. Impaired Neurite Contact Guidance in Ubiquitin Ligase E3a (Ube3a)-Deficient Hippocampal Neurons on Nanostructured Substrates.
    Tonazzini I; Meucci S; Van Woerden GM; Elgersma Y; Cecchini M
    Adv Healthc Mater; 2016 Apr; 5(7):850-62. PubMed ID: 26845073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of ubiquitin ligase E3A in polarized contact guidance and rescue strategies in UBE3A-deficient hippocampal neurons.
    Tonazzini I; Van Woerden GM; Masciullo C; Mientjes EJ; Elgersma Y; Cecchini M
    Mol Autism; 2019; 10():41. PubMed ID: 31798818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study of adhesion and migration dynamics in ubiquitin E3A ligase (UBE3A)-silenced SYSH5Y neuroblastoma cells by micro-structured surfaces.
    Mezzena R; Masciullo C; Antonini S; Cremisi F; Scheffner M; Cecchini M; Tonazzini I
    Nanotechnology; 2021 Jan; 32(2):025708. PubMed ID: 33055385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology.
    Dindot SV; Antalffy BA; Bhattacharjee MB; Beaudet AL
    Hum Mol Genet; 2008 Jan; 17(1):111-8. PubMed ID: 17940072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JNK signaling activation in the Ube3a maternal deficient mouse model: its specific inhibition prevents post-synaptic protein-enriched fraction alterations and cognitive deficits in Angelman Syndrome model.
    Musi CA; Agrò G; Buccarello L; Camuso S; Borsello T
    Neurobiol Dis; 2020 Jul; 140():104812. PubMed ID: 32087286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired hippocampal plasticity and altered neurogenesis in adult Ube3a maternal deficient mouse model for Angelman syndrome.
    Mardirossian S; Rampon C; Salvert D; Fort P; Sarda N
    Exp Neurol; 2009 Dec; 220(2):341-8. PubMed ID: 19782683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Hippocampal Response to Acute Corticosterone Elevation Is Altered in a Mouse Model for Angelman Syndrome.
    Viho EMG; Punt AM; Distel B; Houtman R; Kroon J; Elgersma Y; Meijer OC
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model.
    Silva-Santos S; van Woerden GM; Bruinsma CF; Mientjes E; Jolfaei MA; Distel B; Kushner SA; Elgersma Y
    J Clin Invest; 2015 May; 125(5):2069-76. PubMed ID: 25866966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of hippocampal synapse maturation by activity-regulated E3 ligase via non-canonical pathway.
    Kumari P; Srinivasan B; Banerjee S
    Neuroscience; 2017 Nov; 364():226-241. PubMed ID: 28890050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of nuclear UBE3A activity is the predominant cause of Angelman syndrome in individuals carrying UBE3A missense mutations.
    Bossuyt SNV; Punt AM; de Graaf IJ; van den Burg J; Williams MG; Heussler H; Elgersma Y; Distel B
    Hum Mol Genet; 2021 Apr; 30(6):430-442. PubMed ID: 33607653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the Rho-GEF Pbl/ECT2 is regulated by the UBE3A E3 ubiquitin ligase.
    Reiter LT; Seagroves TN; Bowers M; Bier E
    Hum Mol Genet; 2006 Sep; 15(18):2825-35. PubMed ID: 16905559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial dysfunction in CA1 hippocampal neurons of the UBE3A deficient mouse model for Angelman syndrome.
    Su H; Fan W; Coskun PE; Vesa J; Gold JA; Jiang YH; Potluri P; Procaccio V; Acab A; Weiss JH; Wallace DC; Kimonis VE
    Neurosci Lett; 2011 Jan; 487(2):129-33. PubMed ID: 19563863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UBE3A regulates MC1R expression: a link to hypopigmentation in Angelman syndrome.
    Low D; Chen KS
    Pigment Cell Melanoma Res; 2011 Oct; 24(5):944-52. PubMed ID: 21733131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ube3a reinstatement mitigates epileptogenesis in Angelman syndrome model mice.
    Gu B; Carstens KE; Judson MC; Dalton KA; Rougié M; Clark EP; Dudek SM; Philpot BD
    J Clin Invest; 2019 Jan; 129(1):163-168. PubMed ID: 30352049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Angelman Syndrome protein Ube3A regulates synapse development by ubiquitinating arc.
    Greer PL; Hanayama R; Bloodgood BL; Mardinly AR; Lipton DM; Flavell SW; Kim TK; Griffith EC; Waldon Z; Maehr R; Ploegh HL; Chowdhury S; Worley PF; Steen J; Greenberg ME
    Cell; 2010 Mar; 140(5):704-16. PubMed ID: 20211139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ube3a, the E3 ubiquitin ligase causing Angelman syndrome and linked to autism, regulates protein homeostasis through the proteasomal shuttle Rpn10.
    Lee SY; Ramirez J; Franco M; Lectez B; Gonzalez M; Barrio R; Mayor U
    Cell Mol Life Sci; 2014 Jul; 71(14):2747-58. PubMed ID: 24292889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative proteomics reveals neuronal ubiquitination of Rngo/Ddi1 and several proteasomal subunits by Ube3a, accounting for the complexity of Angelman syndrome.
    Ramirez J; Lectez B; Osinalde N; Sivá M; Elu N; Aloria K; Procházková M; Perez C; Martínez-Hernández J; Barrio R; Šašková KG; Arizmendi JM; Mayor U
    Hum Mol Genet; 2018 Jun; 27(11):1955-1971. PubMed ID: 29788202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity-dependent changes in MAPK activation in the Angelman Syndrome mouse model.
    Filonova I; Trotter JH; Banko JL; Weeber EJ
    Learn Mem; 2014 Jan; 21(2):98-104. PubMed ID: 24434871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UBE3A-mediated p18/LAMTOR1 ubiquitination and degradation regulate mTORC1 activity and synaptic plasticity.
    Sun J; Liu Y; Jia Y; Hao X; Lin WJ; Tran J; Lynch G; Baudry M; Bi X
    Elife; 2018 Jul; 7():. PubMed ID: 30020076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. UBE3A regulates the transcription of IRF, an antiviral immunity.
    Furumai R; Tamada K; Liu X; Takumi T
    Hum Mol Genet; 2019 Jun; 28(12):1947-1958. PubMed ID: 30690483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.